Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis.
Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.
Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
Epigenetic changes in patients with multiple sclerosis.
Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord.
The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.
B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting: Alemtuzumab (BLA 103948\5139) Background Package
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Significant Percentage of MS Patients Receiving Alemtuzumab in Genzyme’s Phase 2 Trial Remain Free of Clinically Active Disease
FTY720 in patients with primary progressive multiple sclerosis (INFORMS)
GEMSP: A New Therapeutic Approach to Multiple Sclerosis.
Predictive value of early brain atrophy on response in patients treated with interferon β.
American Society for Cell Biology Annual Meeting
Specific peripheral B cell tolerance defects in patients with multiple sclerosis.
Transverse myelitis -- a review of the presentation, diagnosis, and initial management.
Teva Presents Data Comparing Early Treatment with COPAXONE® 40 mg/mL to Delayed Start Treatment at 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.
Combination Treatment of Interferon β-1b and Warfarin for a Patient With Baló's Concentric Sclerosis and Antiphospholipid Syndrome.
Drak2 Does Not Regulate TGF-β Signaling in T Cells.
Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report.
[Intractable vomiting as first manifestation of neuromyelitis Optica.]
Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis.
Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome.
MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

Pages